ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
Long-term Impact of Early and Deeper Molecular Response in Newly Diagnosed CML-CP Patients Receiving Radotinib: Three Years Follow-up of Rerise Study
Comments 0
Login to view comments.
Click here to Login
